Introduction
Over the past decade, investigators have refined and capitalised on powerful gene targeting technology in animals to investigate the cellular and integrative physiology and pathophysiology of such complex diseases as atherosclerosis and essential hypertension. [1] [2] [3] Precise genetic interventions, utilising homologous recombination in mouse embryonic stem cells, have provided novel insights into the importance of the renin-angiotensin-aldosterone system (RAAS) in the control of kidney function as well as other tissues and organs. Significant loss of function during renal development and in the regulation of haemodynamics, epithelial transport, excretion of salt and water, and arterial blood pressure (BP) have been elucidated. The genetic absence of specific actions of different angiotensin II (Ang II) AT-receptors results in characteristic phenotypes, some of which have marked abnormalities, whereas others are barely detectable. The resultant multilayered collages reflect graded functional absence or presence of a selected protein, combined with physiological homeostatic adjustments by remaining effective components of the renin-angiotensin system. Compensatory responses of these and other systems contribute significantly to the final phenotypic characteristics. Careful investigation of these geneticallyengineered model systems should contribute to our understanding of how naturally occurring mutations of genes in the renin-angiotensin family cause or contribute to disease processes such as hypertension. This brief review will survey studies that have used gene targeting to evaluate AT-receptor function on the kidney to gain insight into regulatory mechanisms in renal vascular and tubular cells. For additional information, the reader is referred to many recent excellent reviews on this subject. [4] [5] [6] [7] [8] [9] The biological actions of Ang II are mediated by two classes of cell surface, seven transmembranespanning receptors in the superfamily of G proteincoupled protein receptors. [10] [11] [12] AT 1 -and AT 2 -receptors are distinct classes, distinguished by different radioligand binding and affinities for nonpeptide antagonists. The predominance of AT 2 -receptors during foetal development falls rapidly after birth. There is a vast prevalence of AT 1 -over AT 2 -receptors after renal maturation, which is complete at around four weeks of age in rodents. Rats and mice have two subtypes of nearly identical AT 1 -receptors. Most tissues have a predominance of AT 1A -over AT 1Breceptors; anterior pituitary and adrenal glands are exceptions to this rule. In the kidney, receptors are found along most of the vasculature and the nephron. AT-receptors are present on endothelial and smooth muscle cells of arteries, major resistance vessels, afferent and efferent arterioles, juxtamedullary cells, glomerular mesangial and epithelial cells, and vasa recta and medullary interstitial cells. They are present on epithelial cells of most nephron segments, such as the proximal tubule, thick ascending limb of Henle's loop including the macula densa region, and the distal tubule.
Most of the known actions of Ang II on renal function in adult animals are mediated by AT 1 -receptors. [10] [11] [12] Among the many known AT 1 -mediated effects are systemic pressor response, vascular contraction, enhanced renal tubular sodium reabsorption, and aldosterone secretion. AT 2 -receptor function is less well-defined, although an emerging general pattern suggests that AT 2 -receptors act to oppose the effects of AT 1 -receptors in most circumstances. More comprehensive knowledge of the AT 2receptor is important in understanding the clinical beneficial effects of angiotensin-converting enzyme (ACE) inhibition and AT 1 -receptor antagonists. Because all known AT 1 -receptor antagonists bind with equal affinities to AT 1A -and AT 1B -receptors, the relative roles of these receptor subtypes and contributions to in vivo function have been difficult to separate using conventional pharmacological tools. Gene targeting has been useful in discerning specific actions of these receptor subtypes.
An in-depth understanding of the actions of different AT-receptors is predicated on knowing the physiology and pathophysiology of organ systems and integrated function of mammals when Ang II or AT stimulation is totally absent. Pharmacological studies of this nature have been conducted at various time-points in an animal's life. Gene targeting has been utilised to render selected genes nonfunctional throughout life, including foetal as well as adult periods. Examples of this are provided by early studies in which gene targeting has eliminated angiotensinogen, and thus Ang II production. Rendering the ACE genes nonfunctional is another model that serves as a reference for understanding the role of Ang II and AT-receptors in integrated body function. renal function.The absence of Ang II during foetal development and perinatal maturation causes not only hypotension, but also a severe phenotype characterised by grossly abnormal renal structure and function. [13] [14] [15] [16] [17] [18] [19] Worthy of note is that the critical ACE is tissue-bound, rather than circulating enzyme activity. 13 Confirmatory evidence derives from pharmacological studies reporting similar abnormalities in renal morphology when either an ACE inhibitor (ACE-I) or an AT 1 -receptor antagonist is given to animals undergoing nephrogenesis. [20] [21] [22] Homozygous AGT gene mutants have reduced perinatal viability; over 50% of them do not survive until weaning at four weeks of age. Surviving animals are hypotensive. Renal development and morphology is especially sensitive to the complete absence of AGT genes. Major abnormalities include malformed, poorly developed inner medulla/papilla, tubular atrophy, and focal areas of interstitial fibrosis. In addition, there is excessive proliferation of the muscular wall of renal arteries, which seems paradoxical in the absence of the growth-promoting agent Ang II. Marked hyperplasia of juxtaglomerular cells is associated with enhanced renin production and release. Urinary aldosterone, an index of aldosterone production, is very low. Neuronal nitric oxide synthase in the macula densa region of the thick ascending limb is stimulated, as evidenced by NADPH diaphorase reaction, immunohistochemistry, and mRNA expression. Macula densa nitric oxide stimulation of renin production is suggested by inhibition of renin as well as nitric oxide by the putative selective inhibitor of neuronal nitric oxide synthase 7-nitrondazole. 23 Renal function is altered in AGT null mice. In the face of a reduced arterial pressure and activation of the sympathetic nervous system and plasma vasopressin, AGT -/-mice with free access to water are polyuric and excrete a urine more dilute than wild-type controls. 24 The diuresis is primarily due to a renal concentrating defect and impaired tubular reabsorption, which is not unexpected in view of the marked medullary compression and atrophy. This notion is supported further by observations of an inability to increase urinary osmolality above 1600, as compared with 3300 mOsm/kg H 2 O attained by AGT +/+ mice during water deprivation. Because of the pronounced abnormalities of medullary structures, it is difficult to identify precise cellular transport mechanisms responsible for these and other functional defects.
Chronic volume depletion induced by low-salt intake in AGT -/-is associated with reduced GFR and little increase in urinary osmolality, which cannot be increased further by vasopressin challenge. 25 Whether the fall in GFR is due to the absence of Ang II-dependent autoregulatory adjustments in preglomerular vascular resistance is not known. Glomerular volume is noted to be proportional to salt intake, whereas the hypoplastic papilla is insensitive to dietary sodium.
Heterozygotes with one AGT gene inactivated show no upregulation of the remaining normal allele in the liver, the main site of AGT synthesis.
Heterozygotes are less hypotensive than AGT -/-. There are no changes in ACE or AT 1 -receptor density. Plasma renin concentration is twice that of wild-type controls, reflecting an increase in the number of renin-producing cells rather than increased synthesis by the original population. 26 For the sake of brevity, this review will not include a description of animals with ACE gene disruption. As noted above, the general phenotype is similar to that of AGT null animals. For specific details, the reader is referred to several seminal studies on this model, which range from zero to four copies of the ACE gene. 13, 15, 16, 27 With this background, investigators subsequently mutated genes for selective AT-receptors. Recent models include elimination of AT 1 -and AT 2 -receptor function. Most biological effects of Ang II are thought to be mediated by AT 1 -receptors. Rats and mice have two subtypes of AT 1receptor. In cardiovascular and renal cells, AT 1Areceptor density predominates over that of AT 1B + AT 1A -receptor null mice have been useful in identifying Ang II actions associated with the absence of AT 1A -receptors and also those mediated by receptors other than AT 1A .
Phenotype of AT 1A knockout mice
Because of the predominance of AT 1 -and AT 1Areceptors in most cells, an initial prediction was that elimination of Ang II signalling via AT 1A -receptors would produce a severe phenotype. This outcome was not, however, observed. The Durham-Chapel Hill and Nashville laboratories found essentially normal AT 1A -null mice, with no remarkable phenotype. AT 1A -null mice had normal survival rates and their kidneys grew and developed normally. 28, 29 Thus, the absence of AT 1Areceptor function has little impact on fertility, foetal and neonatal development, or overall survival. The renal architecture tends to be basically normal, although subtle abnormalities have been noted. The Nashville group developed chimerical mice with heterogeneous distribution of mutated genes with a lacZ reporter gene replacing the AT 1A -receptor coding region. Co-expression of the β-galactosidase product of the lacZ reporter gene indicates that the AT 1A promoter is localised to afferent arteriolar walls, juxtaglomerular cells, endothelial cells and glomerular mesangial cells, and both apical and basolateral membranes of the proximal tubular cells. 29 Kidneys from AT 1A -null mice show mild renal structural abnormalities, characterised by glomerular mesangial expansion and minimal cortical radial artery hypertrophy, with subtle reductions in inner medulla/papilla size. [28] [29] [30] [31] Autoradiographic studies reveal that most kidney Ang II binding is absent when AT 1A -receptors are deleted. AT 1B -receptor binding in kidney slices is barely detectable, which implies no marked upregulation of AT 1B -receptors in the absence of AT 1A . In AT 1Areceptor heterozygotes,Ang II binding is reduced by about 50%.
AT 1A -receptors are important in BP control and systemic haemodynamic responses to Ang II. 32
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March 2001 Volume 2 Supplement 1 S169 Basal systolic arterial BP is reduced by about 20 mmHg in homozygous AT 1A -/-mice, and the pressor response to Ang II is markedly attenuated. The fact that the pressor effect is more readily apparent after endogenous Ang II production is acutely inhibited, suggests prior occupation of receptors when endogenous levels are high. The acute pressor response, presumably due to an increase in total peripheral vascular resistance, is inhibited by an AT 1 -receptor antagonist and is unaffected by sympatholytic agents. Chronic treatment with an AT 1 -receptor blocker lowers systolic arterial pressure by 8 mmHg. Heterozygous AT 1A +/-animals have a 10 mmHg lower systolic arterial pressure than wild-type.
Ang II produces arteriolar vasoconstriction by activation of AT 1 -receptors. AT 1 -receptors are coupled to G αq proteins that activate phospholipase C and associated signalling pathways, that in turn lead to an increase in cytosolic calcium concentration and contraction of vascular smooth muscle cells. In AT 1A -null mice, Ang II produces a normal increase in cytosolic calcium concentration in aortic smooth muscle cells. 33 The responses of normal and mutated cells are mediated by a combination of calcium mobilisation and entry. The stimulatory effect of Ang II in both wild-type and AT 1A -knockout mice is inhibited by AT 1 -receptor blockers, implicating actions by AT 1B -receptors in the absence of AT 1A . AT 1A and AT 1B appear to signal similarly in natural smooth muscle cells as well as in surrogate cells with transfected receptors.
Ang II exerts negative feedback regulation of renin release from juxtaglomerular cells. In the absence of AT 1A -receptor function, juxtaglomerular renin mRNA and plasma renin activity are elevated, 31 indicating the importance of the role Ang II exerts via the AT 1 -receptor in controlling renin production/release. In contrast, renin levels are largely unaffected by AT 1B and AT 2 -receptor mutations. Nevertheless, there is intact regulation by baroreceptor and macula densa mechanisms in addition to other stimuli, as plasma renin and Ang II respond appropriately to changes in extracellular fluid volume in the absence of AT 1A -receptor function. 34 Although plasma renin activity is markedly elevated in AT 1A -null mice, cortical Ang II levels tend to be lower than normal, suggesting a role for AT 1A -receptors in proximal tubular uptake and sequestration of Ang II.
Regulation of the renal microcirculation in AT 1A -receptor deficient mice
The vast majority of Ang II effects on the renal vasculature in rodents are mediated by AT 1 -receptors. In contrast, AT 2 -receptors are much less prevalent and appear to play a minor role, at least under normal physiological conditions. General characteristics and normal values for renal haemodynamics and excretory function are summarised in a recent review of the renal physiology of the mouse. 35 The function of AT 1B -receptors in the control of renal vascular resistance has been evaluated in AT 1A -null mice, animals with very low levels of AT 2 -receptors in the renal vasculature. A some-what surprising finding is that, in the absence of AT 1A -receptors, Ang II is still able to exert vascular effects in vitro and in vivo. Ang II has been shown to increase cytosolic calcium concentration, constrict arterioles, and elicit a systemic pressor response in AT 1A -/-mice. 33, 36, 37 Blood flow studies utilising an ultrasonic flow transducer in mice, demonstrate that Ang II, injected into the renal artery, can constrict renal arterioles by activating receptors other than AT 1A . 37 Renal vascular reactivity to Ang II is clearly evident in AT 1A -receptor-deficient mice, although responses are attenuated compared with wild-type controls. Reactivity to a given dose of Ang II is less than in controls, and the maximum renal vasoconstrictor response to high concentrations of Ang II is roughly 50% in AT 1A -null animals, as compared with complete cessation of blood flow in control mice. Part of the attenuated response appears to be due to high levels of endogenous Ang II. Renal responsiveness to Ang II administration increases when Ang II production is acutely blocked by either ACE or renin inhibition. The effects of Ang II on the renal microcirculation in AT 1A -receptordeficient mice appear to be mediated by AT 1Breceptors, as Ang II-induced constriction is inhibited by candesartan or losartan. It is not clear whether the attenuated response is due to reduced receptor density of AT 1B (vs. AT 1A + AT 1B in wild-type), as might be expected during the high plasma Ang II concentration, or less efficient post-receptor signal transduction. Normal calcium signalling pathways in aortic smooth muscle cells lends support to the former possibility.
There appear to be interesting differences in AT 1B -receptor distribution between afferent and efferent glomerular arterioles in mice. Although present in the afferent arteriole, AT 1B -receptors seem to be absent in the efferent arteriole, according to immunolocalisation and functional studies. Vasoconstrictor effects of Ang II on afferent and efferent arterioles have been examined in the juxtamedullary nephrovascular preparation. 36, 38 The afferent arterioles lacking AT 1A contract in response to Ang II, but they are less reactive to a given Ang II concentration than wild-type, as noted in earlier studies at the whole kidney level. 37 The response appears to be AT 1B -receptor-mediated, as it could be blocked by an AT 1 -receptor antagonist, such as candesartan. In marked contrast, efferent arterioles appear to lack AT 1B -receptors, based on the observations that Ang II had no effect on vascular tone and that the vessels were unresponsive to AT 1 -receptor blockade, during both basal and Ang II challenge conditions. At variance with this work is a report on the chronically hydronephrotic model of AT 1A -null mice, suggesting that Ang II-induced vasoconstriction is mediated exclusively by AT 1A -receptors on both afferent and efferent arterioles. 39 The reason why afferent arterioles failed to respond to exogenous Ang II in this particular study is not clear. Possibilities include prior AT 1B -receptor occupation by high levels of endogenous Ang II and/or down-regulation of AT 1B -receptors during the stressful Clearance studies confirm the flowmetry information of normal renal blood flow (PAH clearance) and extend the finding to include normal GFR values (inulin clearance). 34 Under basal conditions of hypotension and autoregulation of renal haemodynamics, both absolute and fractional sodium excretion were similar to wild-type controls. Thus, it appears that the AT 1B -receptor is capable of maintaining function in response to increased plasma Ang II. It is noteworthy that renal Ang II levels are reduced in the face of elevated plasma Ang II, suggesting a role of the AT 1B -receptor in proximal tubular sequestration of Ang II.
The influence of Ang II on tubuloglomerular feedback (TGF) in AT 1A -null mice has been tested in micropuncture studies. 35, 40, 41 Maximal TGF activity was assessed by increasing late proximal perfusion rate from 0 to 40 nl/min to increase the delivery-dependent signal sensed by macula densa cells. In control mice, high tubular flow caused a 9 mmHg decrease in glomerular capillary pressure, estimated by proximal tubular stop-flow pressure. Heterozygous AT 1A +/-had 50% inhibition of TGF. Homozygous AT 1A -/-mice had virtually no TGF. These groups were not challenged with exogenous Ang II, as were ACE-knockout mice (see below).The results indicate that the Ang II effect on TGF control of afferent arteriolar resistance is primarily mediated by the AT 1A -receptor. It is noteworthy that exogenous Ang II is capable of causing a renal vasoconstriction and a systemic pressor response in AT 1A -null mice, presumably by acting on AT 1B -receptors. 32, 36, 37 On the other hand, the AT 1Areceptor is important in the regulation of renin release, mediating Ang II-induced short-loop negative feedback inhibition in juxtaglomerular cells.
TGF is also affected in animals with mutated ACE genes. 40, 42 Mice with one ACE gene have attenuated TGF activity, as maximum stimulation of macula densa control of afferent arteriolar tone causes only a 2 mmHg decrease in glomerular pressure. In the absence of any functional ACE,TGF is non-existent. However, the vasculature remains responsive to exogenous Ang II. Systemic infusion of Ang II at non-pressor doses increases TGF-mediated preglomerular vasoconstriction, independent of ACE activity. The maximum decrease in glomerular pressure was increased to a similar extent in all animals, irrespective of ACE gene copy number.
Regulation of salt and water excretion in AT 1B -receptor deficient animals
The AT 1A -receptor plays an important role in the regulation of BP and sodium balance. Several studies have addressed the issue of whether arterial pressure is low because of withdrawal of Ang II effects on vascular smooth muscle cells or on renal tubular epithelial cells.The questions are: is there less vasoconstriction and a lower peripheral vascular resistance, or is there less stimulation of tubular salt transport leading to extracellular fluid volume contraction? Recent studies suggest the AT 1A -/-mouse is a model of salt/volume-depen-dent hypotension because of impaired ability to retain salt. 34 Support for this view derives from the observation that acute extracellular fluid volume expansion produces larger increases in mean arterial pressure and reductions in plasma Ang II concentration in AT 1A -null mice than in wild-type controls. Thus, arterial pressure is saltsensitive in AT 1A -null mice, whereas in wild-type it is salt-insensitive. Acute volume expansion produces equivalent increases in absolute and fractional sodium excretion in AT 1A -knockout and control mice. The increases in renal plasma flow and GFR were also similar in the two groups.
A chronic high-salt diet increases systolic arterial pressure (79-94 mmHg), an effect reversed by sodium restriction (pressure fall from 82-69 mmHg) in AT 1A -/-mice. 43 The reduction in arterial pressure in the AT 1A -/-group fed a low-salt diet for seven days, was associated with negative cumulative sodium balance as compared with neutral balance in wild-type controls. Urinary excretion of aldosterone is normal in AT 1A -/-mice, indicating primary regulation of aldosterone production by other AT-receptors and/or plasma electrolytes. These observations support the view that AT 1A -receptors play an important role in control of sodium balance and contribute to sodium sensitivity of arterial pressure. Accordingly, the low arterial pressure in AT 1A -receptor null mice can be explained, at least in part, by depletion of sodium and extracellular volume.
AT 1A -receptors are also important in the maintenance of water balance. Mice deficient in AT 1Areceptor function display impaired ability to concentrate their urine, even though there are no gross structural abnormalities in the medulla. 44 A defect in urinary concentrating ability is evidenced by excretion of a less-than-maximally concentrated urine (2000 vs. 3500 mOsm/kg in controls) after 12 hours of water deprivation. The inability to retain appropriate amounts of water leads to increased serum osmolality and elevated plasma antidiuretic hormone concentration.
In summary, deletion of AT 1A -receptors has more pronounced effects on cardiovascular and renal function than on renal development and morphology. AT 1A -receptors are important in the regulation of arterial BP and peripheral vascular resistance, including renal vasomotor tone, TGF control of afferent arteriolar tone, renin release from juxtaglomerular cells, proximal tubular uptake of Ang II, tubular sodium reabsorption and overall sodium balance, and the kidney's ability to produce maximally concentrated urine and maintain water balance. The effects of Ang II to increase cytosolic calcium concentration, constrict arterioles, and elicit a systemic pressor response in AT 1A -receptor deficient mice can be inhibited by an AT 1 -receptor antagonist, suggesting mediation by AT 1B -receptors. At the other end of the spectrum, AT 1A -receptor function does not appear to be essential for intrinsic autoregulation of renal blood flow and GFR, aldosterone secretion, and appropriate renal excretory responses to acute volume expansion.
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Phenotype of AT 1B knockout mice
Two independent laboratories have shown that homozygous deletion of the AT 1B -receptor gene in mice has little influence on the normal phenotype. 45, 46 The absence of a functional AT 1B -receptor has no effect on intrauterine development or perinatal survival. Adult animals are normotensive and have normal morphology and histology of the heart, kidney, and adrenal glands. AT 1B -null mice exhibit typical pressor responses to systemic injection of Ang II, and plasma aldosterone concentration is within the normal range. No upregulation of AT 1A mRNA is apparent in kidneys or adrenal glands. These observations indicate that critical regulation of Ang II actions are retained, the majority of AT-receptors are AT 1A in the organs of interest, and that AT 1A -receptors are able to adequately assume the function of the removed AT 1Breceptors. Conversely,AT 1B -receptors assume some, but not all, of AT 1A functions in their absence.
Phenotype of double AT 1A and AT 1B knockout mice
Simultaneous inactivation of both AT 1 -receptors produces a severe renal phenotype similar to that observed in AGT -/-and ACE -/-mice. 46, 47 These findings are in accord with pharmacological studies demonstrating that AT 1 -receptor-mediated signalling is essential for normal renal development. Mutation of both AT 1 -receptor genes leads to retarded generalised growth. For example, body mass is reduced by 10-15%, and kidney and heart weights are reduced by 20-30%. In particular, renal structure is deranged. Double AT 1A + AT 1B -null animals have abnormal kidney morphology, with delayed maturity in glomerular growth, atrophy of the inner medulla with a hypoplastic papilla, and renal arterial hypertrophy. The underlying mechanisms are not certain. Possibilities include a deficiency of growth factors in the medulla or indirect effects secondary to abnormal development of the pelvic-ureteral junction and chronic increases in pelvic pressure. The ureteral smooth muscle is hypoplastic and lacks peristaltic movements, leading to hydronephrosis. Hypercellularity of arterioles accompanies shorter, thicker and fewer cortical radial arteries and afferent arterioles. Proliferative changes are noted in the interstitium, small arteries, juxtaglomerular apparatus and glomeruli.
Deletion of both AT 1 -receptors renders rodents hypotensive; systolic arterial pressure drops from 123-87 mmHg. Furthermore, the normal pressor response to injected Ang II is completely absent. In contrast, the pressor effect of epinephrine is unaffected. Noteworthy is that acute Ang II does not lower pressure further, arguing against a vasodilator role of AT 2 -receptors in the absence of AT 1 -receptors. In contrast, chronic ACE inhibition produces a 7 mmHg increase in arterial pressure. The fact that chronic, but not acute, inhibition of Ang II production has an effect on arterial pressure has been the basis of a contention that Ang II is acting by mechanisms other than directly on peripheral vascular resistance. One possibility is that the lack of antinatriuretic AT 1 -receptors leads to salt loss and contraction of extracellular fluid volume and volume-dependent hypotension. Alternatively, volume contraction may be due to Ang II exerting an AT 2 -receptor-mediated tubular natriuretic effect.
As one might predict from the major morphological changes, renal function is abnormal in the double AT 1A + AT 1B knockout animals. The ability to concentrate the urine is markedly impaired in AT 1A + AT 1B knockout mice and more severe than seen in AT 1A -null mice. Chronic water restriction leads to only a limited increase in urinary osmolality. Following water deprivation for 12 hours, the maximum urinary osmolality in double AT 1 knockouts is 1000 as compared with 2500 in AT 1A -null and 3500 mOsm/kg in wild-type controls. Papillary and outer medullary atrophy appears to be responsible for a urinary concentrating defect and polyuria.
General conclusions, based on comparisons of AT 1A and double AT 1A + AT 1B -null mice, are that the absence of either AT 1 -receptor isoform alone can be compensated for by the presence and function of the other isoform. AT 1 -receptors are clearly required for normal development of the renal medulla and pelvis, BP control, and regulation of salt and water balance.
AT 2 -receptor function
With the exception of high levels before birth, vascular and renal expression of AT 2 -receptors is very low in adult animals. The function of AT 2 -receptors is controversial. Many studies have used pharmacological antagonists to provide generally negative results concerning AT 2 -receptor function in cardiovascular and renal systems under physiological conditions. On the other hand, AT 2 -effects appear to be more readily discernible during more extreme situations, such as chronic salt deprivation. In this state of volume depletion, renal expression of AT 2 -receptors appears to be upregulated and natriuretic effects on tubular reabsorption are reported by the Charlottesville group. 4,48 AT 2 -receptor signalling is thought to be mediated by a non-G-protein coupled pathway, possibly related to stimulation of bradykinin, nitric oxide, and/or cytochrome P450 metabolites in the epoxyeicosatrienoic acid (EET) and/or monohydroxyeicosatetraenoic acid (HETE) families. Microdialysis of renal interstitial fluid in sodiumrestricted animals suggests that basal production of bradykinin, nitric oxide and cGMP are elevated. Other evidence implicates AT 2 -mediated nitric oxide production in association with pressuredependent natriuresis and diuresis. 48, 49 On the other hand, another laboratory provides results suggesting that AT 2 -receptors stimulate, rather than inhibit, sodium reabsorption, exerting effects independent of changes in cGMP. 50, 51 Recently,AT 2 -receptor function has been examined in genetic models in which AT 2 -receptor genes are rendered nonfunctional or are overexpressed. 52, 53 Animals without AT 2 function appear to develop normally, are born in normal numbers, and survive to adulthood. The kidneys from AT 2 -null mice are morphologically normal in general. More detailed subsequent analyses reveal a small but significant increased incidence of congenital anomalies of the kidney and urinary tract, suggesting that this receptor class participates in the development of the genitourinary tract. 54 During certain conditions,AT 2 -receptor stimulation appears to produce vasodilation and to inhibit tubular sodium reabsorption, thereby counteracting AT 1 -mediated vasoconstriction and sodium retention. Disruption of the AT 2 -receptor is associated with increased BP, measured by the tail-cuff method, in restrained animals and an enhanced pressor response to administered Ang II. 49, 52, 53, 55 More recent telemetry data demonstrate slight hypertension throughout diurnal patterns in unrestrained AT 2 -null mice. 56 Interestingly, arterial pressure is not increased further in response to salt loading, either with or without DOCA.
The circulating Ang II concentration is normal in AT 2 -receptor null mice. 57 Circulating and tissue ACE activity is elevated in heart, lung and kidney, and infusion of Ang I causes a larger pressor response in AT 2 -null mice than in wild-type. 58 Levels of bradykinin and cGMP in the renal interstitial fluid are reduced and fail to respond to Ang II infusion (or volume depletion), whereas wildtype mice exhibit a 4-fold increase in bradykinin and cGMP levels. 49 Thus, AT 2 -receptor stimulation tonically inhibits renal ACE and stimulates renal production of bradykinin and nitric oxide. In one report, infusion of Ang II at a low dose (4 pmol/kg/min) for seven days increased systolic pressure by almost 90 mmHg and exerted marked antinatriuresis, reducing sodium excretion from 0.6-0.05 mmol/day. In contrast, this amount of Ang II affected neither arterial pressure nor sodium excretion in wild-type mice. 49 AT 2 -receptors have been overexpressed in the vasculature in a model in which the AT 2 -receptor gene was coupled to smooth muscle-specific αactin promoter. Excess AT 2 -receptors are able to completely abolish the chronic pressor action of Ang II, without altering AT 1 -receptor density in aortic smooth muscle cells. The vasodilatory depressor action mediated by AT 2 -receptors appears to involve an endothelium-dependent mechanism, whereby increased production of bradykinin and BK 2 -receptor activation leads to stimulation of nitric oxide and cGMP. 59 Possible AT 2 -mediated changes in kidney function and salt balance cannot be excluded in this model of AT 2overexpression. As in the vasculature, renal AT 2receptors and their stimulation of bradykinin and nitric oxide are thought to play a counterregulatory protective role against the renal tubular antinatriuretic actions of physiological concentrations of Ang II mediated by AT 1 -receptor activation.
Renal function in AT 2 -null mice
The AT 2 -receptor knockout mice exhibit changes in renal function. In these moderately hypertensive animals, the chronic pressure natriuresis curve is shifted to the right, such that a higher renal perfusion pressure is required to excrete the same amount of sodium as control wild-type mice. 60 Thus, steady-state sodium excretion is normal in the face of 13 mmHg higher arterial pressure. Autoregulatory mechanisms maintain GFR and RBF, as is also the case for cortical and medullary blood flow. Assessment of sodium excretion as a function of short-term changes in perfusion pressure, reveals that the acute pressure-natriuresis curve is shifted to the right in AT 2 -receptor null mice. Microsomal production of 20-HETE, a lipid that inhibits salt transport in the thick ascending limb of Henle's loop, is markedly reduced in AT 2 -/-animals. Other systems that can influence sodium reabsorption are also altered in AT 2 -null mice. As mentioned earlier, mice deficient of AT 2 -receptors have lower intrarenal levels of bradykinin and cGMP, an index of nitric oxide levels. 49 An unresolved question is whether the moderate hypertension in AT 2 -/-mice is due to increased sensitivity to the direct AT 1 constrictor action of Ang II on resistance arterioles in the absence of opposing AT 2 -mediated dilation. An alternative possibility, one that is not mutually exclusive, is that the hypertension is a consequence of unopposed AT 1 action on renal epithelial cells, which stimulates sodium retention and increases extracellular fluid volume. The result of this scenario is salt-sensitive and volume-dependent hypertension. There is evidence to support both views, and more experiments are required to resolve these important issues. A direct action on the vasculature is supported by a report that Ang II causes greater contraction of aortic rings in vitro and greater increases in total peripheral resistance in vivo in AT 2 -receptor-deficient animals. 55 With regard to sodium excretion, renal AT 1 -receptors are upregulated 2.5-fold, so one might predict a stronger than normal Ang II effect on tubular reabsorption AT 2 -receptor function. 60 An AT 2 -receptor sensitive to the putative selective antagonist PD 123319 is reported to stimulate dilation when AT 1 -receptors are blocked in isolated microperfused rabbit afferent and efferent arterioles. The vasodilation appears to be endothelium-dependent, mediated by a cytochrome P450 metabolite of arachidonic acid, and unaffected by inhibition of nitric oxide synthase or cyclooxygenase. 61, 62 However, not all evidence points to a vasodilator role of apparent AT 2 -receptors, or at least a type of AT-receptor antagonised by PD 123319. In vivo studies in wild-type and AT 1Anull mice show that a moderate, consistent portion (20-30%) of the renal vasoconstriction produced by Ang II can be blocked by PD 123319. 37 The observation of inhibiting, not enhancing, renal vasoconstriction as well as receptor binding has been made in rats. 63 It is not clear whether this component of Ang II-induced constriction is due to an AT 2 -receptor, or a new class of AT-receptors distinct from classical AT 1 -receptors.
Summary
Transgenic mice lacking different Ang II receptors provide new insights and interesting perspectives about the function of the renin-angiotensin system
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March 2001 Volume 2 Supplement 1 S173 REVIEW and of specific Ang II AT-receptors. In general, the lessons we have learned about the AT 1 -and AT 2receptor classes from gene targeting confirm and extend results obtained from pharmacological studies. Marked changes in renal morphology are seen in mice with homozygous disruption of AGT, ACE and both AT 1 -receptor genes, as is the case for chronic pharmacological inhibition of ACE or AT 1receptors. On the other hand, novel observations have come from studies of AT 1A -and AT 1B -receptor function in the absence of the other; at present, pharmacological agents cannot distinguish between the two AT 1 -receptor subtypes. A brief summary of known and proposed actions of AT 1and AT 2 -receptors is presented in Table 1 .
Deletion of AT 1A -receptors has significant functional effects on the cardiovascular and renal systems. Renal development and morphology are usually altered only slightly. AT 1A -receptors play important regulatory roles for arterial BP and peripheral vascular resistance, including renal vasomotor tone, tubuloglomerular feedback of preglomerular vascular resistance, the kidney's ability to produce maximally concentrated urine, tubular sodium reabsorption, and maintenance of sodium and water balance. AT 1A -receptor function does not appear to be essential for intrinsic autoregulation of renal blood flow and GFR, aldosterone secretion, and appropriate renal excretory responses to acute volume expansion.AT 1B -receptors seem to be redundant, duplicating the effects of AT 1A and thereby serving as a reserve system to reinforce the actions of AT 1A , if present. AT 1Breceptor density is considerably less than that of AT 1A , and the prevalence of AT 1A -receptors appears to explain why deletion of AT 1B -receptors has little impact on phenotype. On the other hand, AT 1B -receptors exert important functions in AT 1A -null mice, preventing them from developing the more severe phenotype seen when both AT 1 -receptors are rendered nonfunctional. Double AT 1A + AT 1B knockout mice have major abnormalities, recapitulating the severe phenotype observed in the absence of the substrate AGT or ACE. There are effects of deletion of AT 2 -receptors on cardiovascular and renal function. At present, it is difficult to know if the responses are due to functional upregulation of AT 1 -receptors or deletion of AT 2 -receptors. Some investigators believe AT 2 -receptors are almost nonexistent and have very weak or no actions, at least under normal physiological conditions. Other investigators hold that AT 2 -receptors exert actions that oppose those of AT 1 -receptors, generally acting to produce vasodilation and sodium excretion.
These and other questions and issues will have to be resolved by further investigation. Ever expanding are the complexity and multiple actions of the renin-angiotensin-aldosterone system that is now recognised as important locally in the kidney and other organs in addition to being a hormonal system in the general circulation. Future studies utilising regional gene targeting in a specified cell type and programmable initiation of a gene's loss or gain of function will undoubtedly answer some of the pressing current uncertainties, as well as pose intriguing new questions. 
